NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Intellia Therapeutics, Inc. (NASDAQ:NTLA) on behalf of long-term stockholders following a class action complaint that was filed against Intellia on February 11, 2025 with a Class Period from July 30, 2024 to January 8, 2025. Our investigation concerns whether the board of directors of Intellia have breached their fiduciary duties to the company.

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ:SMLR) on behalf of Semler stockholders. Our investigation concerns whether Semler has violated the federal securities laws and/or engaged in other unlawful business practices.

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) on behalf of Fulgent stockholders. Our investigation concerns whether Fulgent has violated the federal securities laws and/or engaged in other unlawful business practices.

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Apple Inc. (“Apple” or the “Company”) (NASDAQ:AAPL) on behalf of Apple stockholders. Our investigation concerns whether Apple has violated the federal securities laws and/or engaged in other unlawful business practices.

SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced the pricing of its previously announced underwritten public offering of 2,222,222 shares of its common stock at a public offering price of $9.00 per share. In addition, Gyre has granted the underwriters of the offering an option for a period of 30 days to purchase up to an additional 333,333 shares of its common stock at the public offering price, less the underwriting discounts and commissions.

Autodesk, Inc. (NASDAQ:ADSK ) Q1 2026 Earnings Conference Call May 22, 2025 5:00 PM ET Company Participants Simon Mays-Smith - VP, IR Andrew Anagnost - CEO Janesh Moorjani - CFO Conference Call Participants Saket Kalia - Barclays Jay Vleeschhouwer - Griffin Securities Adam Borg - Stifel Jason Celino - KeyBanc Capital Markets Elizabeth Porter - Morgan Stanley Bhavin Shah - Deutsche Bank Joe Vruwink - Baird Taylor McGinnis - UBS Michael Turrin - Wells Fargo Siti Panigrahi - Mizuho Ken Wong - Oppenheimer & Company Joshua Tilton - Wolfe Research Tyler Radke - Citi Operator Thank you for standing by, …

Amazon's latest shareholder results, released Thursday afternoon, show a continued decline in support for some high-profile environmental and social proposals.

StepStone Group Inc. (NASDAQ:STEP ) Q4 2025 Results Conference Call May 22, 2025 5:00 PM ET Company Participants Seth Weiss - Head, Investor Relations Scott Hart - Chief Executive Officer Mike McCabe - Head-Strategy David Park - Chief Financial Officer Jason Ment - President and Co-Chief Operating Officer Conference Call Participants Ken Worthington - JPMorgan Ben Budish - Barclays Michael Cyprys - Morgan Stanley Chris Kotowski - Oppenheimer Operator Thank you for standing by, and welcome to the StepStone Group's Fiscal Fourth Quarter 2025 Earnings Conference Call. At this time, all participants are in listen-only mode.

NEW YORK, NY / ACCESS Newswire / May 22, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=149862&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 22, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=149861&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 22, 2025 / If you suffered a loss on your UnitedHealth Group Incorporated (NYSE:UNH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/unitedhealth-group-incorporated-lawsuit-submission-form?prid=149863&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq.

ROCKVILLE, Md. and SUZHOU, China, May 22, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, today announced that new clinical data from two ongoing investigational studies evaluating lisaftoclax in various blood cancers and alrizomadlin in solid tumors will be presented during an oral presentation and poster presentation, respectively, at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 30 - June 3 in Chicago, Ill., USA. Both lisaftoclax and alrizomadlin demonstrated antitumor activity, and the data support their further clinical development.

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of UnitedHealth Group Incorporated (NYSE: UNH) between December 3, 2024 and May 12, 2025, both dates inclusive (the “Class Period”), of the important July 7, 2025 lead plaintiff deadline in the securities class action commenced by the firm.

SAN DIEGO , May 22, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all persons or entities that purchased or otherwise acquired Ibotta, Inc. (NYSE: IBTA) securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Ibotta's April 18, 2024 initial public offering, or between April 18, 2024 and February 26, 2025. Ibotta purports to be a technology company that allows consumer packaged goods brands to deliver digital promotions to millions of consumers through its network called the Ibotta Performance Network.

NEW YORK , May 22, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ: VTRS) between August 8, 2024 and February 26, 2025, both dates inclusive (the "Class Period"), of the important June 3, 2025 lead plaintiff deadline. So what: If you purchased Viatris securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Deckers Outdoor Corporation (NYSE:DECK ) Q4 2025 Earnings Conference Call May 22, 2025 4:30 PM ET Company Participants Erinn Kohler - VP, IR & Corporate Planning Stefano Caroti - President & CEO Steve Fasching - CFO Conference Call Participants Jonathan Komp - Baird Jay Sole - UBS Laurent Vasilescu - BNP Paribas Samuel Poser - Williams Trading John Kernan - TD Cowen Rick Patel - Raymond James Financial Operator Good afternoon, and thank you for standing by. Welcome to the Deckers Brands Fourth Quarter Fiscal 2025 Earnings Conference Call.

NEW YORK--(BUSINESS WIRE)---- $WST #CLASSACTIONLAWSUIT--The law firm of Kirby McInerney LLP reminds investors who purchased West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE:WST) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at [email protected], or fill out the contact form below, to discuss your rights or interests with respect to the securities fraud class action lawsuit against the Company. [CONTACT FORM] The lawsuit was filed on behalf of investors who acquired West secu.

OMAHA, Neb. & SINGAPORE--(BUSINESS WIRE)--ACI Worldwide (NASDAQ: ACIW), an original innovator in global payments technology, today announced that CIMB Bank, one of ASEAN's leading banking groups and Malaysia's second largest financial services provider, has chosen ACI's payment solution to converge all account-to-account transactions—real-time, ACH, RTGS and cross-border—onto a single future-proof payments platform. As the industry pushes toward ISO 20022 standardization, this new ISO20022-nati.

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new data from several studies of compounds discovered by HUTCHMED including savolitinib, ranosidenib, fruquintinib and surufatinib, will be presented at the American Society of Clinical Oncology (“ASCO”) Annual Meeting taking place on May 30 – June 3, 2025 in Chicago, USA.

Intuit Inc. (NASDAQ:INTU ) Q3 2025 Earnings Conference Call May 22, 2025 4:30 PM ET Company Participants Kim Watkins - VP of IR Sasan Goodarzi - CEO Sandeep Aujla - CFO Conference Call Participants Siti Panigrahi - Mizuho Brad Zelnick - Deutsche Bank Alex Zukin - Wolfe Research Raimo Lenschow - Barclays Kash Rangan - Goldman Sachs Kirk Materne - Evercore ISI Allan Verkhovski - Scotiabank Brent Thill - Jefferies Michael Turrin - Wells Fargo Securities Scott Schneeberger - Oppenheimer Daniel Jester - BMO Capital Markets Operator Good day, everyone. My name is David, and I will be your conference …